Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Free prostate-specific antigen in serum is becoming more complex.

Literature DB >> 12031356

Free prostate-specific antigen in serum is becoming more complex.

Stephen D Mikolajczyk¹, Leonard S Marks, Alan W Partin, Harry G Rittenhouse.

Abstract

Entities: Gene

Mesh：

Substances：

Year: 2002 PMID： 12031356 DOI： 10.1016/s0090-4295(01)01605-3

Source DB: PubMed Journal: Urology ISSN： 0090-4295 Impact factor: 2.649

Keyword Cloud
Cited

× No keyword cloud information.

38 in total

1. Prospective evaluation of operating characteristics of prostate cancer detection biomarkers.

Authors: Yuanyuan Liang; Donna P Ankerst; Norma S Ketchum; Barbara Ercole; Girish Shah; John D Shaughnessy; Robin J Leach; Ian M Thompson
Journal: J Urol Date: 2010-11-12 Impact factor: 7.450

2. [-2]Proenzyme prostate specific antigen is more accurate than total and free prostate specific antigen in differentiating prostate cancer from benign disease in a prospective prostate cancer screening study.

Authors: Brian V Le; Christopher R Griffin; Stacy Loeb; Gustavo F Carvalhal; Donghui Kan; Nikola A Baumann; William J Catalona
Journal: J Urol Date: 2010-02-19 Impact factor: 7.450

3. Evolving Role of Pro-PSA as a New Serum Marker for the Early Detection of Prostate Cancer.

Authors: Masood A Khan; Alan W Partin
Journal: Rev Urol Date: 2002

4. Twenty Years of PSA: From Prostate Antigen to Tumor Marker.

Authors: Gabriela De Angelis; Harry G Rittenhouse; Stephen D Mikolajczyk; L Blair Shamel; Axel Semjonow
Journal: Rev Urol Date: 2007

5. A prospective, multicenter, National Cancer Institute Early Detection Research Network study of [-2]proPSA: improving prostate cancer detection and correlating with cancer aggressiveness.

Authors: Lori J Sokoll; Martin G Sanda; Ziding Feng; Jacob Kagan; Isaac A Mizrahi; Dennis L Broyles; Alan W Partin; Sudhir Srivastava; Ian M Thompson; John T Wei; Zhen Zhang; Daniel W Chan
Journal: Cancer Epidemiol Biomarkers Prev Date: 2010-05 Impact factor: 4.254

Review 6. A comprehensive approach toward novel serum biomarkers for benign prostatic hyperplasia: the MPSA Consortium.

Authors: Chris Mullins; M Scott Lucia; Simon W Hayward; Jeannette Y Lee; Jonathan M Levitt; Victor K Lin; Brian C-S Liu; Arul M Chinnaiyan; Mark A Rubin; Kevin Slawin; Robert A Star; Robert H Getzenberg
Journal: J Urol Date: 2008-02-20 Impact factor: 7.450

Free prostate-specific antigen in serum is becoming more complex.

1. Prospective evaluation of operating characteristics of prostate cancer detection biomarkers.

2. [-2]Proenzyme prostate specific antigen is more accurate than total and free prostate specific antigen in differentiating prostate cancer from benign disease in a prospective prostate cancer screening study.

3. Evolving Role of Pro-PSA as a New Serum Marker for the Early Detection of Prostate Cancer.

4. Twenty Years of PSA: From Prostate Antigen to Tumor Marker.

5. A prospective, multicenter, National Cancer Institute Early Detection Research Network study of [-2]proPSA: improving prostate cancer detection and correlating with cancer aggressiveness.

Review 6. A comprehensive approach toward novel serum biomarkers for benign prostatic hyperplasia: the MPSA Consortium.

Review 7. Screening for prostate cancer: an update.

Review 8. Aberrant PSA glycosylation--a sweet predictor of prostate cancer.

Review 9. Biomarkers for benign prostatic hyperplasia progression.

10. Assays for prostate cancer : changing the screening paradigm?